Transgenic expression or injections of RBP4 was able to induced insulin resistance in a mouse model, in contrast to the reduction of RBP4 expression with improved insulin resistance in diet-induced obesity (Aeberli et al., 2007[2]). Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.